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Abstract
The last several decades have seen many advances in the recognition and prevention of the abdominal
compartment syndrome (ACS) and its precursor, intra-abdominal hypertension (IAH). There has also been a relative
explosion of knowledge in the critical care, trauma, and surgical populations, and the inception of a society
dedicated to its understanding, the World Society of the Abdominal Compartment Syndrome (WSACS). However,
there has been almost no recognition or appreciation of the potential presence, influence, and management of
intra-abdominal pressure (IAP), IAH, and ACS in pregnancy. This review highlights the importance and relevance of
IAP in the critically ill parturient, the current lack of normative IAP values in pregnancy today, along with a review
of the potential relationship between IAH and maternal diseases such as preeclampsia-eclampsia and its potential
impact on fetal development. Finally, current IAP measurement guidelines are questioned, as they do not take into
account the gravid uterus and its mechanical impact on intra-vesicular pressure.
Review
Introduction
Despite the nearing deadline for attaining the World
Health Organization’s Millennium Development Goals
that include improving maternal health worldwide by
2015, the reality remains that over one-half million expec-
tant or new mothers die suddenly and unpredictably [1,2].
Although 90% of these deaths occur in developing coun-
tries, intensivists in developed nations are also confronted
by unexpected critical illnesses in pregnancy, often in
otherwise previously healthy women. These illnesses, most
commonly preeclampsia and obstetric hemorrhage, can
result in significant morbidity and mortality in both
mother and newborn [3,4]. Further complicating the situa-
tion, intensivists are often unfamiliar with maternal-fetal
physiology both in health and in critical illness [3], and
perhaps do not consider the possible impact of intra-
abdominal pressure (IAP) and intra-abdominal hyperten-
sion (IAH) on such conditions.
Since the inception of the World Society of the
Abdominal Compartment Syndrome (WSACS) in 2004,
many advances in the recognition, the treatment, and
especially the prevention of the abdominal compartment
syndrome (ACS) have occurred [5,6]. When clinicians
are vigilant and make efforts to detect and treat raised
IAP, it appears that deadlyA C Sm a yo f t e nb ea v o i d e d ,
especially with the adoption of newer resuscitation strate-
gies [7,8]. Such advances have led some to propose that
the future efforts of the WSACS should be focused on
the more prevalent but less understood precursor condi-
tion of IAH, rather than the overtly catastrophic ACS.
This rapid evolution in practice in the fields of critical
care and trauma has been associated with a relative
explosion in the published world literature, focusing on
critical care, trauma, medical, and surgical populations
[9].
However, despite seminal work early in the twentieth
century by an obstetrician, Paramore [10], there has been
almost no recognition or appreciation of the potential
presence, influence, and management of IAH in preg-
nancy and the peripartum state, other than dramatic case
reports in which ACS was only recognized in a parturient
in extremis [11-13]. As pregnancy is a natural but dra-
matic physiologic state that can occur at some point in
the lifetime of approximately half of the world’sp o p u l a -
tion, further understanding and research is urgently
needed. Critical illness in pregnancy, unfortunately, is not
uncommon, given that the population-based incidence of
severe obstetric morbidity has been reported to be as
high as 1.2% in the UK [14]. In the USA, the American
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overall estimate that critical care services were required
in 1% to 3% of pregnant women [4], in whom diagnoses
of maternal hypertension and hemorrhage were the most
cited causes of critical care admission [4]. The relevance
of greater understanding and education in both the beha-
vior and measurement of the IAP in pregnancy is illu-
strated by the following case, aspects of which, primarily
relating to the infectious etiology of the case, have
previously been described [15].
Illustrative case
A 16-year-old female, estimated to be at 32 weeks gesta-
tion, was transferred to a tertiary intensive care unit (ICU)
from a peripheral hospital. She required intubation and
ventilation following a 2-week prodrome of progressive
cough. Her ICU admission revealed severe hypoxemia
with a PaO2/FiO2 ratio of 53, despite receiving 100% frac-
tional inspired oxygen (FiO2). Her initial lactate was
2.1 mmol/l, hemoglobin was 10.5 g/dl, and creatinine was
58 μmol/l with a urine output of greater than 30 ml/h.
Her physiologic data can be found in Table 1. A fetal
ultrasound revealed a poor biophysical profile score of 2/8;
however, under conditions of maternal sedation and phar-
macologic paralysis, this was non-diagnostic in determin-
ing fetal well-being. There was a normal amniotic fluid
volume and a fetal heart rate of 156 beats/min. As a result,
the obstetrical consult regarding the issue of fetal delivery
was noncommittal, and the patient was inadvertently lost
to follow up by obstetrics during her subsequent ICU
course.
The patient was ventilated using high-frequency oscil-
latory ventilation in combination with nitric oxide (NO),
but the oxygenation did not improve significantly. Within
15 h of admission, bilateral chest tubes were required for
presumed barotrauma-related pneumothoraces. She
became anuric in association with a rising creatinine of
122 μmol/l. Nine hours later, she further decompensated,
requiring an increase of the mean airway pressure
(MAWP) to 50 cmH2O. The central venous pressure
(CVP) increased to 27 mmHg, and severe subcutaneous
emphysema developed ‘from head to toe’.T r a n s t h o r a c i c
echocardiography revealed a hyperdynamic, underfilled
heart. She continued to deteriorate, prompting a consult
to cardiac surgery for extracorporeal life support (ECLS)
as a last resort to her spiraling physiologic decline.
Obstetrics was re-consulted and noted that sono-
graphic windows during a repeat fetal ultrasound were
completely absent. After much debate, it was decided
that cannulation for ECLS would precede a caesarean
section (CS). In the operating room, the ECLS cannula-
tion procedure proved difficult and prolonged, resulting
in iatrogenic injuries to both the groin and subclavian
vessels, and transfusion of six units of red blood cells.
Finally, after cannulation, the ECLS circulatory flows
were inadequate at 1 to 1.5 l/min.
Thereafter, the CS was performed by a midline laparot-
omy. Upon incising the peritoneum, an unexpected gush
of air was released. There was an immediate improvement
in mechanical ventilation; pulse oximetry (SpO2)i n c r e a s e d
above 90% for the first time since her admission. The
ECLS flows only improved partially. The fetus was suc-
cessfully delivered within 20 min. Upon evacuation of the
uterus, there was a distinct improvement in the patient’s
ventilation and oxygenation. The ECLS flows immediately
improved to normal levels (4 to 4.5 l/min); SpO2 was
100%; and the NO and jet ventilator were quickly weaned.
There was a spontaneous diuresis of clear urine intrao-
peratively. The neonate was intubated after delivery,
immediately taken to the neonatal intensive care unit, and
eventually discharged on day 27 but had multiple hospital
admissions thereafter.
Postoperatively, the inciting etiology of fulminant adult
respiratory distress syndrome (ARDS) was determined to
be caused by a severe influenza A infection, prompting
publication of a plea for routine vaccination of all eligible
patients with the influenza vaccine, although no mention
of the potential role of ACS was made [15]. The mother
herself underwent 2 weeks of ECLS support, repeated
upper gastrointestinal bleeding due to systemic heparini-
zation, the administration of 98 units of blood products,
and several ECLS circuit thromboses. Although no preo-
perative IAP measurements had been obtained, post-
operative IAP was 14 mmHg. She was discharged home 6
weeks later.
The evidence to support the conclusion that ACS signif-
icantly contributed to her spiraling decline included the
high MAWP of 50 mmHg, a well-described inciting factor
for tension pneumoperitoneum [16-22]. The progressive
worsening of her ventilatory parameters, anuria, and ele-
vated CVP in the face of a normal cardiac function, almost
completely relieved by the release of a large ‘gush’ of air
during laparotomy, strongly supported the contention that
her ARDS was complicated by an unrecognized but classic
presentation of fulminant ACS [23,24].
Table 1 Physiologic variables of reported case
Admission Prior to laparotomy
MAWP = 44.5 mmHg MAWP = 50 mmHg
SpO2 = 83% SpO2 = 80%
FiO2 = 100% FiO2 = 100%
7.32/52/53/26 BE = 0 mmol/l 7.23/83/55/33 BE = 4 mmol/l
UO = 27 to 185 ml/h UO = 0 ml/h
CVP = 14 mmHg CVP = 24 mmHg
No inotrope support Norepinephrine = 0.06 μg/kg/min
MAWP, mean airway pressure; SpO2, pulse oximetry; FiO2, fractional inspired
oxygen; BE, base excess; UO, urine output; CVP, central venous pressure.
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As IAH/ACS impacts almost all of the body’s organ sys-
tems, it is important for intensivists to understand the
normal alterations in these systems that occur with
pregnancy. The pregnant state involves a complex and
remarkable interplay of both adaptive and supportive
physiology, allowing a fetus to grow and thrive for a
finite duration in utero until such time it is ready for a
physically independent life. The maternal physiologic
changes that occur in pregnancy are multisystemic and
far-reaching, not the least of which is the adaptation to
accommodate the gravid uterus. On average, the uterus
contributes 1 kg to the overall weight gain in pregnancy,
while the amniotic fluid, fetus, and placenta comprise
approximately 5 kg in additional weight [25].
To accommodate this growth, the thoracic cage
increases in both anteroposterior and transverse dia-
meters [25]. The hormone relaxin, released by the corpus
luteum and placenta, results in targeted softening of the
ligamentous structures to also compensate for uterine
growth [26]. The diaphragm becomes elevated as a result
of being pushed cephalad by the uterus, impeding the
functional residual capacity by at least 20% [25]. Tidal
volume increases and is associated with a 45% increase in
minute and alveolar ventilation [25]. Overall maternal
metabolic rate, oxygen consumption (VO2), gas
exchange, and acid/base balance are all affected by sev-
eral factors including the growth of the feto-placental
unit, progesterone levels, and carbon dioxide production.
On average, maternal VO2 increases by 15% to 20% [27],
although in one study, VO2 increased with advancing
gestation by 28% [28]. With increased ventilation, the
resulting respiratory alkalosis is renally compensated
through a reduction of serum bicarbonate to 20 mEq/L
and total buffer base capacity to 5 mEq/L [25]. Thus,
when critically ill, the parturient is more vulnerable to
hypoxemia and acidemia, with overall less physiologic
reserve, than when nonpregnant [27].
In addition, there is a 50% increase in plasma volume
resulting in dilutional anemia and overall increase in circu-
lating blood volume of 40% [25,27]. Cardiac output
increases by 30% to 50%; blood flow to the gravid uterus
increases tenfold [27]. After 20 weeks of gestation, the
uterus size can cause a mechanical aorto-caval obstruction
while fully supine and can result in the ‘supine-hypoten-
sive syndrome’: significant loss of venous return for which
the cardiovascular system cannot compensate [25]. How-
ever, the majority of women develop collateral circulation
through interosseus vertebral, paravertebral, epidural, and
ovarian venous systems [25]. It has been suggested that
those who suffer from supine-hypotensive syndrome likely
do not develop adequate collateral circulation [29]. While
only approximately 8% of women at term experience this
life-threatening situation, significant compression of the
inferior vena cava (IVC) while supine does occur in the
majority of women [25,29]. Whether elevated IAP can
exacerbate aorto-caval compression and has a relationship
with this syndrome is unknown. Thus, due to the myriad
of hormonal, mechano-physiologic changes, the majority
of parturients are well compensated for the exponential
growth of their fetus in a relatively short duration of time.
IAP and pregnancy
Knowledge of normal versus pathologic IAPs for any
population in the ICU would seem intuitive for patient
care [30]. To date, however, there is very little actual data
regarding physiologic and pathophysiologic IAP in preg-
nancy. Current consensus guidelines group pregnancy
and morbid obesity together as chronically compensated
states of IAH [31]. However, the growth of each gesta-
tional age during pregnancy as well as the unique ana-
tomic impact as the uterus grows from the pelvis into the
abdominal cavity has never been taken into account.
Unlike pregnancy, chronic obesity is the deposition of fat
diffusely throughout the abdominal cavity. The implica-
tion of this anatomical difference could be considered
semantic by some, but could be considered significant,
given that the standard of measurement of IAP uses the
intra-vesicular pressure as a surrogate; the location of
which rests in the pelvis.
The state of the science in this regard is well symbolized
by the fact that until very recently, the best evidence con-
cerning IAP in pregnancy was obtained through rectal
manometry on primarily primigravid inmates of an institu-
tion for ‘fallen women’ and published in 1913 [10]. More
recently, however, Al-Khan and colleagues [32] published
more contemporary IAP intravesical measurements in 100
healthy term parturients obtained under spinal anesthesia
just prior to commencement of elective CS. These and all
IAP data to date can be found in Table 2. They found the
median IAP in a leftward tilted position to be 22 ±
2.9 mmHg (range 15 to 29 mmHg), pressures actually in
the threshold range for ACS if organ failure were also pre-
sent [31]. Postoperatively, after neonatal delivery, the IAP
dropped significantly to a median IAP of 16 mmHg (range
11 to 24 mmHg) [32]. Besides questions regarding the
fluid volume of bladder priming for IAP measurement and
unknown spinal anesthesia dermatome distribution, the
greatest question from this study is the unspecified degree
of left lateral tilt during the IAP measurements, making it
difficult to reconcile if these measurements reflected the
actual abdominal IAP or the weight of the gravid uterus
on the bladder itself.
We similarly measured the IAP in 20 term parturients
under spinal anesthesia [33]. The IAP measurement was
significantly higher in the fully supine position (0°) com-
pared to when the operating table was leftward tilted to
10° with the reference point held constant by placing
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patient on an intravenous pole. We thus hypothesized
that the weight of the gravid uterus might have directly
impacted on the bladder, thereby falsely elevating the
IAP measurement when fully supine.
Thus, the above studies highlight currently unresolved
issues regarding the necessary trade-offs between the use
of a standardized and reproducible reference position to
obtain meaningful IAP data, and the reality of patient
safety. This is akin to the concern regarding the position-
ing of ventilated patients fully supine to measure IAP,
while increasing aspiration risks [30,34,35]. Left lateral tilt
has become the standard of care in CS, particularly after
spinal anesthesia, as a means to both facilitate CS and alle-
viate potential aorto-caval compression while supine [36].
There is debate as to the degree of tilt required to mini-
mize compression of the IVC by the uterus [36,37]; a tilt
of 15° is generally recommended [36]. What remains
unknown is the effect of the gravid uterus on measured
bladder pressure in varying relative positions to each
other. Questions arise as to the validity of the IAP mea-
surement as recommended by the WSACS guidelines in a
pregnant patient from early second trimester onwards.
Current recommended guidelines describe IAP measure-
ment in the fully supine position at end-expiration [38,39].
Such a maneuver in pregnancy, however, could be detri-
mental. Clearly, more studies are needed to validate IAP
measurement in this unique population.
The potential role of IAH in preeclampsia-eclampsia
Preeclampsia, part of a spectrum of hypertensive disorders
of pregnancy, is defined as the development of arterial
hypertension and proteinuria after 20 weeks gestation [40]
and is associated with significant maternal morbidity and
death [4,40]. Preeclampsia-eclampsia, clinically, can pre-
sent with one or more manifestations of either renal com-
promise, neurological sequelae including visual
disturbances, headache, stroke, and eventually convulsions
(eclampsia), to thrombocytopenia, fetal growth restriction,
and liver and other hematologic abnormalities [41].
HELLP is considered a severe variant of preeclampsia and
manifests as a syndrome of hemolysis, elevated liver
enzymes, and low platelet count [41]. While some of these
clinical manifestations, particularly eclampsia, have been
well described as early as the mid-1600’s [42], modern
understanding of the etiology remains incomplete. The
most commonly held hypothesis is that abnormal placen-
tation occurs during the myometrial trophoblastic invasion
in the second trimester [40], leading to placental ischemia
and the release of angiogenic toxins, causing widespread
endothelial dysfunction [41] and generalized inflammation.
However, this immune maladaptation hypothesis has been
recently questioned [43] as a result of recent epidemiologic
studies. While its incidence worldwide is significant (3% to
5% of all pregnancies) [40], preeclampsia is a heteroge-
neous condition for which its commoner presentation in
younger women in developing countries may be etiologi-
cally distinct than that of the somewhat older preeclamptic
presentation in developed nations, with clinically [30]
milder disease occurring later in gestation [43].
Two dramatic case reports described overt ACS as a
complication of preeclampsia-eclampsia/HELLP syn-
dromes requiring urgent life-saving interventions [12,13].
The diagnosis of peripartum ACS in these cases was chal-
lenging not only due to the lack of well-established nor-
mative pregnant values of IAP, but also because of the
overlap of signs and symptoms between ACS and severe
preeclampsia such as oliguria and nonspecific abdominal
pain [12]. Furthermore, we contend that ACS was unrec-
ognized in these cases because the routine measurement
of IAP generally has not been accepted in many ICUs.
Akin to many other conditions in critical illness, clini-
cians too frequently do not consider the possible impact
of IAH in the clinical picture, especially when the patient
has not been injured or subjected to surgery [44,45].
Even as early as the 1900s, investigators had suggested
uncompensated elevated IAP as a possible etiologic factor
in the development of preeclampsia [10,46]. While ele-
vated IAP may not be the only, sole, or critical inciting fac-
tor, its potential role in the development or progression of
Table 2 Physiologic IAP in pregnancy
Author Year n Gestation Positions during IAP
measurement
IAPmean
(mmHg)
Comments
Paramore
[10]
1913 24 6 months to
term
Supine; left side; knee
chest; standing
Range
15 to 44
Rectal manometer; ambulatory subjects
Cuppett et
al. [62]
2008 40 Term Supine;
Left Lateral
Not
reported
Elective CS under spinal anesthesia
Sugerman
[49]
2011 5 39 weeks Supine;
Left Lateral decubitus
25 ± 3;
23 ± 3
Unclear methods; likely ambulatory patients
Al-Khan et
al. [32]
2011 100 36 to 41
weeks
Leftward tilt 22 ± 2.9 Elective CS; Unspecified leftward tilt; 50 ml saline instilled in
bladder; unclear reference point
Chun et al.
[33]
2012 20 38 to 40
weeks
Supine;
Leftward tilt
10 ± 4.7
8.9 ± 4.9
Elective CS under spinal anesthesia; leftward tilt 10
0
IAPmean, mean intra-abdominal pressure; n, number; CS, caesarean section.
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the preponderance of ‘toxemia’ of pregnancy in primiparas
in 1694 [42]. Paramore, also noting this prevalence,
hypothesized that nulliparous and muscular women were
prone to spastic abdominal wall tone resulting in elevated
IAPs, compromising perfusion pressure to the abdomino-
pelvic viscera [10,46]. Mulier was able to indeed confirm a
linear relationship between abdominal pressure and
volume to calculate the abdominal wall elastance (E) [47]
and even found that E decreased significantly with
increased age and gravidity [48]. Sugerman recently
hypothesized that IAH played a central role in initiating
the multi-system cascade of diminished perfusion and
inflammation associated with the various clinical manifes-
tations of preeclampsia [49]. He speculated obstructed
venous return from IAH, essentially limiting abdominal
perfusion pressure due to increased back pressure,
resulted in decreased end-organ perfusion including both
kidneys and the placenta. Thus, the activation of the
renin-angiotensin system, with elevation of aldosterone
levels, systemic hypertension, and placental ischemia/
necrosis with an impact on fetal growth, was triggered
[49].
That ACS occurs in this patient population is not
really the question. Given the evidence in the literature
to date (Table 1), it is likely that term pregnancy is asso-
ciated with elevated IAP to which the patient has
adapted. It is also likely that the IAP is elevated in the
immediate postpartum phase as well [32,50], similar to
the postoperative surgical populations [51]. What
remains to be seen is whether preeclamptic patients
truly have IAH, at what pressure does this occur, and
whether IAH has a significant role the in the progres-
sion of the development of severe preeclampsia or
HELLP.
IAH and the fetus
Despite the limited understanding of IAH in maternal
care, even less is known regarding its effects on the
fetus. Whether there are subclinical effects of even mod-
est elevations of maternal IAP on the fetus is completely
unknown. Several animal studies have confirmed that
the mammalian fetus in utero is subject to transmitted
IAP [52,53]. IAH was found to decrease uterine blood
flow and induce a resultant compensatory fetal hyper-
tension [54] such as during laparoscopy even with inert
gasses rather than CO2. In a gravid rabbit model, Kar-
nak et al. examined the relationship between maternal
IAP and intra-amniotic pressure (IAMNP) through
catheters inserted into both the intraperitoneal and
intra-amniotic cavities at 20 days of gestation. Intraperi-
toneal air was insufflated to an IAP of 20 cmH2O. They
found that IAMNP was linearly related to IAP as
d e f i n e db yI A M N P=I A P×0 . 8+2 . 0 .F u r t h e r ,t h e y
found that the elevation of IAMNP to 15.6 cmH2Ov i a
the elevation of the IAP (to 17 cmH2O) altered the con-
tractile properties of the fetal bladder [53].
While we are aware of no modern human data corre-
lating maternal IAH with any known effects on the
fetus, concerns regarding the fetal-placental unit are
neither entirely novel nor implausible. Tanyel [55]
hypothesized that elevated IAMNP is translated to ele-
vated fetal IAP, both of which were vulnerable to eleva-
tions in maternal IAP [55]. Through this mechanism,
elevated fetal IAP could result in increased urethral
resistance, the chronicity of which could lead to abnor-
mal development of the bladder detrusor muscles, resul-
tant dysfunctional voiding in children, and possible
urinary tract anomalies [55]. Although the etiology of
such syndromes is likely multifactorial, exploration of
the impact of pathological maternal IAH on the feto-
placental unit could be another area of fruitful potential
investigation.
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome (OHSS) is a not an
uncommon complication of ovulation induction for
assisted reproduction [56,57]. The mechanism is not
entirely understood but is thought to be mediated by
vasoactive cytokines in response to exogenous adminis-
tration of human chorionic gonadotropin [58]. Signifi-
cant third spacing as a result of capillary vascularity due
to ovarian neoangiogenesis can occur [56], and in its
most severe form, massive and rapid accumulation of
abdominal ascites results in an overt ACS [58]. Manage-
ment for this condition ranges from conservative obser-
vation to intensive care admission with IAP monitoring
and paracentesis to relieve ACS [57,58]. As assisted
reproduction increases inp r e v a l e n c e ,i tb e c o m e s
imperative to recognize this relatively common compli-
cation and to consider the potential role of IAH in its
pathophysiology.
Like OHSS, rapid growth in abdominal girth, dyspnea,
abdominal pain, and other overt symptoms of ACS in
other gynecological conditions must also be considered
in the differential. Patients undergoing ovulation induc-
tion are also at increased risk of ovarian torsion and
ectopic pregnancy [57]. Meigs’ syndrome, solid ovarian
tumors associated with hydrothorax and ascites, has
been described similarly to OHSS in presenting with
symptoms of ACS [59]. However, while OHSS is often
self-limited with conservative management as a viable
option, definitive therapy for Meigs’ syndrome would be
surgical removal of the tumor itself [59].
Conclusions
It is currently a recommended standard for any newly
admitted critically ill patient with any two IAH risk
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cally ill pregnant patient typically has positive generic
risk factors for IAH such as ‘acute respiratory failure
with elevated intrathoracic pressures’ and ‘increased
abdominal contents’ in later pregnancy, in addition to
those specific to their inciting illness. If IAP is not mea-
sured, IAH will often be missed. Further, the lack of
knowledge of the behavior of IAH in pregnancy risks
the potential disaster of missed or delayed diagnosis of
ACS resulting in morbidity and mortality in a relatively
young and otherwise healthy cohort. Despite these high
stakes, there is almost no data to guide evidence-based
decisions. At the bedside, measuring the IAP and con-
sidering IAH in all critical maternal conditions is essen-
tial, especially in preeclampsia-eclampsia where some
have hypothesized that IAH may have an additional
role. Research is urgently needed to define the normal
r a n g eo fI A Pi na l lp h a s e so fp r e g n a n c y .T h i sm a yb e
better facilitated with the validation of less invasive IAP
measurement alternatives such as the measurement of
wall tension [60] or via gastric tonometry [61]. The IAP
in pregnancy must take into account the precautions for
aorto-caval compression. The potential impact of mater-
nal IAH on fetal development is essentially unknown.
Finally, IAH leading to ACS is a real and potential com-
plication in early induced pregnancy. Measurement of
the IAP should be performed in the management of
OHSS.
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